Cargando…

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis

BACKGROUND: The World Health Organization (WHO) has set ambitious targets for the elimination of onchocerciasis by 2020–2025 through mass ivermectin treatment. Two different mathematical models have assessed the feasibility of reaching this goal for different settings and treatment scenarios, namely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolk, Wilma A., Walker, Martin, Coffeng, Luc E., Basáñez, María-Gloria, de Vlas, Sake J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618738/ https://www.ncbi.nlm.nih.gov/pubmed/26489937 http://dx.doi.org/10.1186/s13071-015-1159-9

Ejemplares similares

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
por: Hamley, Jonathan I D, et al.
Publicado: (2021)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae
por: Coffeng, Luc E., et al.
Publicado: (2013)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa
por: Kim, Young Eun, et al.
Publicado: (2017)

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal
por: Walker, Martin, et al.
Publicado: (2017)

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
por: Kura, Klodeta, et al.
Publicado: (2023)

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa
por: Borsboom, Gerard JJM, et al.
Publicado: (2003)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022)

Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa
por: Turner, Hugo C., et al.
Publicado: (2014)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2020)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost
por: Coffeng, Luc E., et al.
Publicado: (2013)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
por: Blok, David J, et al.
Publicado: (2020)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015)

Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa
por: Kim, Young Eun, et al.
Publicado: (2015)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study
por: Turner, Hugo C., et al.
Publicado: (2013)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
por: Diawara, Lamine, et al.
Publicado: (2009)

Correction: Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa
por: Kim, Young Eun, et al.
Publicado: (2015)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
por: Vieira, Juan Carlos, et al.
Publicado: (2007)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador
por: Anselmi, Mariella, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_579sklin8cmuv9ne9kk9bkoep9